EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Low-cord orchidectomy for testicular cancer: what would be different?

Ege A Sarıkaya, Volkan Şen, Kutsal Yörükoğlu, Ozan Bozkurt

World Journal of Urology · 19.07.2024 · 42 (1)

DOI: 10.1007/s00345-024-05118-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Urology, online erschienen am 19.07.2024. Verfasst von Ege A Sarıkaya und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey. ege.sarikaya@deu.edu.tr. Hauptthemen laut MEDLINE: Testicular Neoplasms, Orchiectomy, Neoplasm Invasiveness, Spermatic Cord. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dokuz Eylül University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

High cord radical orchidectomy (HRCO) is accepted as the standard surgical approach in testicular cancer, however low cord orchidectomy (LCRO) can reduce the morbidity of operation without worsening the oncological outcomes.

Methods

We retrospectively re-examined the specimens of men to determine the level of spermatic cord invasion (SCI). Men who had proximal SCI with negative surgical margins after HRCO were assumed to have de-novo residual tumour if LCRO was performed. Others were assumed as oncologically similar. We examined the relation between pre-operative variables and SCI and proximal SCI to determine whether prediction of proximal SCI is possible.

Results

196 patients were included. 22 (11%) had SCI and ten (5%) had proximal SCI. Four patients with proximal SCI had positive surgical margins even after HRCO and didn’t require additional local treatment. Six patients were assumed to have de-novo residual tumour if LCRO was performed. All six patients were metastatic and had systemic chemotherapy. High platelet count, tumour size, N stage, S stage and M stage were all significantly related with both SCI and proximal SCI (p < 0.05).

Conclusion

Due to low probability of SCI, we think LCRO can safely be performed to reduce morbidity in Stage 1 patients. Although there is a risk for residual tumour in Stage 2–3 patients, currently there is no data that residual tumour would impair the success of systemic chemotherapy. Therefore we can not assume that these patients would be negatively affected. Pre-operative data can be useful to predict the presence of proximal SCI and select appropriate patients for LCRO.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Testicular NeoplasmsOrchiectomyNeoplasm InvasivenessSpermatic CordHumansMaleRetrospective StudiesAdultMiddle AgedYoung AdultNeoplasm StagingAged

Stichwörter der Autor:innen

Low-cord orchidectomySpermatic cord invasionSub-inguinal orchidectomyTesticular cancer

Autor:innen und Institutionen

  • Department of Urology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey. ege.sarikaya@deu.edu.tr.
  • Department of Urology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey.
  • Department of Pathology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey.

Förderung

  • Dokuz Eylül University

Zitieren

APA

Sarıkaya, E. A., Şen, V., Yörükoğlu, K., & Bozkurt, O. (2024). Low-cord orchidectomy for testicular cancer: what would be different?. World Journal of Urology, 42(1). https://doi.org/10.1007/s00345-024-05118-7

Vancouver

Sarıkaya EA, Şen V, Yörükoğlu K, Bozkurt O. Low-cord orchidectomy for testicular cancer: what would be different?. World Journal of Urology. 2024;42(1). doi:10.1007/s00345-024-05118-7

BibTeX
@article{Sarkaya2024,
  author = {Sarıkaya, Ege A and Şen, Volkan and Yörükoğlu, Kutsal and Bozkurt, Ozan},
  title = {Low-cord orchidectomy for testicular cancer: what would be different?},
  journal = {World Journal of Urology},
  year = {2024},
  volume = {42},
  number = {1},
  doi = {10.1007/s00345-024-05118-7}
}
Kostenlos starten →